vs

Side-by-side financial comparison of Aurinia Pharmaceuticals Inc. (AUPH) and Resolute Holdings Management, Inc. (RHLD). Click either name above to swap in a different company.

Resolute Holdings Management, Inc. is the larger business by last-quarter revenue ($117.7M vs $77.1M, roughly 1.5× Aurinia Pharmaceuticals Inc.). Aurinia Pharmaceuticals Inc. runs the higher net margin — 273.4% vs -1.5%, a 274.8% gap on every dollar of revenue.

Aurinia Pharmaceuticals Inc. is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for autoimmune and kidney diseases. Its lead approved product is Lupkynis for adult active lupus nephritis treatment, with core operations in North America and European markets, focusing on nephrology and rare immunology therapeutic segments.

Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.

AUPH vs RHLD — Head-to-Head

Bigger by revenue
RHLD
RHLD
1.5× larger
RHLD
$117.7M
$77.1M
AUPH
Higher net margin
AUPH
AUPH
274.8% more per $
AUPH
273.4%
-1.5%
RHLD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AUPH
AUPH
RHLD
RHLD
Revenue
$77.1M
$117.7M
Net Profit
$210.8M
$-1.7M
Gross Margin
88.6%
55.7%
Operating Margin
43.1%
30.2%
Net Margin
273.4%
-1.5%
Revenue YoY
28.8%
Net Profit YoY
14651.2%
EPS (diluted)
$1.52
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AUPH
AUPH
RHLD
RHLD
Q4 25
$77.1M
$117.7M
Q3 25
$73.5M
$120.9M
Q2 25
$70.0M
$119.6M
Q1 25
$62.5M
$103.9M
Q4 24
$59.9M
Q3 24
$67.8M
Q2 24
$57.2M
Q1 24
$50.3M
Net Profit
AUPH
AUPH
RHLD
RHLD
Q4 25
$210.8M
$-1.7M
Q3 25
$31.6M
$-231.0K
Q2 25
$21.5M
$-611.0K
Q1 25
$23.3M
$-3.4M
Q4 24
$1.4M
Q3 24
$14.3M
Q2 24
$722.0K
Q1 24
$-10.7M
Gross Margin
AUPH
AUPH
RHLD
RHLD
Q4 25
88.6%
55.7%
Q3 25
88.9%
59.0%
Q2 25
89.8%
57.5%
Q1 25
86.3%
52.5%
Q4 24
90.7%
Q3 24
91.1%
Q2 24
84.4%
Q1 24
84.6%
Operating Margin
AUPH
AUPH
RHLD
RHLD
Q4 25
43.1%
30.2%
Q3 25
40.5%
34.3%
Q2 25
28.7%
34.0%
Q1 25
35.0%
24.7%
Q4 24
-2.8%
Q3 24
17.3%
Q2 24
-2.6%
Q1 24
-26.3%
Net Margin
AUPH
AUPH
RHLD
RHLD
Q4 25
273.4%
-1.5%
Q3 25
42.9%
-0.2%
Q2 25
30.7%
-0.5%
Q1 25
37.4%
-3.2%
Q4 24
2.4%
Q3 24
21.2%
Q2 24
1.3%
Q1 24
-21.4%
EPS (diluted)
AUPH
AUPH
RHLD
RHLD
Q4 25
$1.52
$-0.20
Q3 25
$0.23
$-0.03
Q2 25
$0.16
$-0.07
Q1 25
$0.16
$-0.39
Q4 24
$0.00
Q3 24
$0.10
Q2 24
$0.01
Q1 24
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AUPH
AUPH
RHLD
RHLD
Cash + ST InvestmentsLiquidity on hand
$80.2M
$205.5M
Total DebtLower is stronger
$169.8M
Stockholders' EquityBook value
$581.3M
$6.5M
Total Assets
$751.6M
$333.4M
Debt / EquityLower = less leverage
26.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AUPH
AUPH
RHLD
RHLD
Q4 25
$80.2M
$205.5M
Q3 25
$72.9M
$148.0M
Q2 25
$52.9M
$99.9M
Q1 25
$66.1M
$71.0M
Q4 24
$83.4M
Q3 24
$36.6M
Q2 24
$33.3M
Q1 24
$63.9M
Total Debt
AUPH
AUPH
RHLD
RHLD
Q4 25
$169.8M
Q3 25
$173.4M
Q2 25
$177.1M
Q1 25
$180.7M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AUPH
AUPH
RHLD
RHLD
Q4 25
$581.3M
$6.5M
Q3 25
$365.8M
$10.8M
Q2 25
$335.3M
$9.6M
Q1 25
$350.2M
$8.9M
Q4 24
$377.5M
Q3 24
$388.0M
Q2 24
$364.6M
Q1 24
$359.5M
Total Assets
AUPH
AUPH
RHLD
RHLD
Q4 25
$751.6M
$333.4M
Q3 25
$527.5M
$293.2M
Q2 25
$502.6M
$253.3M
Q1 25
$504.9M
$214.3M
Q4 24
$550.6M
Q3 24
$549.4M
Q2 24
$523.5M
Q1 24
$516.6M
Debt / Equity
AUPH
AUPH
RHLD
RHLD
Q4 25
26.03×
Q3 25
16.01×
Q2 25
18.42×
Q1 25
20.38×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AUPH
AUPH
RHLD
RHLD
Operating Cash FlowLast quarter
$45.7M
$196.1M
Free Cash FlowOCF − Capex
$189.2M
FCF MarginFCF / Revenue
160.8%
Capex IntensityCapex / Revenue
5.8%
Cash ConversionOCF / Net Profit
0.22×
TTM Free Cash FlowTrailing 4 quarters
$313.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AUPH
AUPH
RHLD
RHLD
Q4 25
$45.7M
$196.1M
Q3 25
$44.4M
$59.6M
Q2 25
$44.2M
$48.9M
Q1 25
$1.3M
$18.4M
Q4 24
$30.1M
Q3 24
$17.0M
Q2 24
$15.8M
Q1 24
$-18.6M
Free Cash Flow
AUPH
AUPH
RHLD
RHLD
Q4 25
$189.2M
Q3 25
$58.6M
Q2 25
$47.5M
Q1 25
$17.8M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
AUPH
AUPH
RHLD
RHLD
Q4 25
160.8%
Q3 25
48.5%
Q2 25
39.7%
Q1 25
17.1%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
AUPH
AUPH
RHLD
RHLD
Q4 25
5.8%
Q3 25
0.8%
Q2 25
1.2%
Q1 25
0.6%
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
AUPH
AUPH
RHLD
RHLD
Q4 25
0.22×
Q3 25
1.41×
Q2 25
2.06×
Q1 25
0.06×
Q4 24
21.07×
Q3 24
1.19×
Q2 24
21.94×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AUPH
AUPH

Products$74.2M96%
License Collaboration And Royalty Revenue$2.9M4%

RHLD
RHLD

Segment breakdown not available.

Related Comparisons